We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMTD
401
DELISTED
TD Ameritrade Holding Corp
AMTD
| $815K | 0.08% |
+16,298
| New | +$883K |
|
|
INFO
402
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $808K | 0.08% |
14,864
+4,766
| +47% | +$249K |
|
403
Cognizant
CTSH
$25.6B
| $807K | 0.08% |
+11,134
| New | +$779K |
|
404
Central Pacific Financial
CPF
$1.01B
| $806K | 0.08% |
27,963
+17,667
| +172% | +$496K |
|
405
Navient
NAVI
$892M
| $806K | 0.08% |
69,645
+30,172
| +76% | +$345K |
|
|
BEDU
406
DELISTED
Bright Scholar Education Holdings
BEDU
| $803K | 0.08% |
19,405
+12,005
| +162% | +$516K |
|
407
Radware
RDWR
$1.17B
| $802K | 0.08% |
30,681
-41,638
| -58% | -$1.02M |
|
408
Hess Midstream
HESM
$5.13B
| $801K | 0.08% |
37,780
-2,019
| -5% | -$43.2K |
|
409
Amdocs
DOX
$6.28B
| $799K | 0.08% |
+14,775
| New | +$831K |
|
410
LeMaitre Vascular
LMAT
$1.85B
| $797K | 0.08% |
25,700
-339
| -1% | -$9.05K |
|
411
Integra LifeSciences
IART
$1.33B
| $796K | 0.08% |
+14,292
| New | +$728K |
|
|
MASI
412
DELISTED
Masimo
MASI
| $796K | 0.08% |
5,755
-3,997
| -41% | -$502K |
|
|
MEET
413
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $793K | 0.08% |
157,608
-28,792
| -15% | -$160K |
|
414
Albany International
AIN
$1.74B
| $792K | 0.08% |
11,060
+6,760
| +157% | +$482K |
|
415
Citizens Financial Group
CFG
$30.5B
| $792K | 0.08% |
24,368
+8,367
| +52% | +$290K |
|
416
GoDaddy
GDDY
$11.4B
| $791K | 0.08% |
10,515
+6,635
| +171% | +$467K |
|
417
Healthcare Realty
HR
$6.92B
| $791K | 0.08% |
+27,683
| New | +$770K |
|
418
ICF International
ICFI
$1.54B
| $791K | 0.08% |
10,393
+3,344
| +47% | +$236K |
|
419
Carlisle Companies
CSL
$15.2B
| $789K | 0.08% |
6,436
+1,855
| +40% | +$214K |
|
420
HubSpot
HUBS
$10.4B
| $788K | 0.08% |
+4,741
| New | +$751K |
|
421
Apple Hospitality REIT
APLE
$3.77B
| $787K | 0.08% |
48,272
+33,524
| +227% | +$537K |
|
422
Prestige Consumer Healthcare
PBH
$2.58B
| $787K | 0.08% |
26,300
-9,000
| -25% | -$258K |
|
423
Selective Insurance
SIGI
$5.77B
| $787K | 0.08% |
+12,440
| New | +$783K |
|
|
FLIR
424
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $787K | 0.08% |
16,531
+10,942
| +196% | +$529K |
|
425
Visteon
VC
$2.75B
| $786K | 0.08% |
+11,666
| New | +$878K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.